US 9675692
Stabilized formulations containing anti-DLL4 antibodies
granted A61KA61K39/39533A61K39/39591
Quick answer
US patent 9675692 (Stabilized formulations containing anti-DLL4 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K39/39533, A61K39/39591, A61P, A61P17/06